BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17039659)

  • 1. Etanercept responsive acrodermatitis continua of Hallopeau: is a pattern developing?
    Bonish B; Rashid RM; Swan J
    J Drugs Dermatol; 2006 Oct; 5(9):903-4. PubMed ID: 17039659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau.
    Weisshaar E; Diepgen TL
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):489-92. PubMed ID: 17537042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau.
    Adişen E; Oztaş M; Gürer MA
    Int J Dermatol; 2007 Nov; 46(11):1205-7. PubMed ID: 17988345
    [No Abstract]   [Full Text] [Related]  

  • 4. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
    Kazinski K; Joyce KM; Hodson D
    J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
    Thielen AM; Barde C; Marazza G; Saurat JH
    Dermatology; 2008; 217(2):137-9. PubMed ID: 18503258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
    Silpa-archa N; Wongpraparut C
    J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
    Nikkels AF; Piérard GE
    J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
    [No Abstract]   [Full Text] [Related]  

  • 8. Acrodermatitis continua resistant to etanercept: therapeutic challenge and unfortunate outcome.
    Gokdemir G; Kutlu S; Köşlü A
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):345-7. PubMed ID: 18554224
    [No Abstract]   [Full Text] [Related]  

  • 9. Two years of experience with etanercept in recalcitrant psoriasis.
    Ahmad K; Rogers S
    Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept therapy for silicone granuloma.
    Desai AM; Browning J; Rosen T
    J Drugs Dermatol; 2006 Oct; 5(9):894-6. PubMed ID: 17039657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
    Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
    J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
    Lutz V; Lipsker D
    Arch Dermatol; 2012 Mar; 148(3):297-9. PubMed ID: 22431771
    [No Abstract]   [Full Text] [Related]  

  • 14. Using oral tetracycline and topical betamethasone valerate to treat acrodermatitis continua of hallopeau.
    Piquero-Casals J; Fonseca de Mello AP; Dal Coleto C; Fonseca Takahashi MD; Simonsen Nico MM
    Cutis; 2002 Aug; 70(2):106-8. PubMed ID: 12234156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration.
    Hernandez-Illas M; Tozman E; Fulcher SF; Jundt JW; Davis J; Pflugfelder SC
    Eye Contact Lens; 2004 Jan; 30(1):2-5. PubMed ID: 14722460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case of acrodermatitis continua accompanied by psoriatic arthritis.
    Jo SJ; Park JY; Yoon HS; Youn JI
    J Dermatol; 2006 Nov; 33(11):787-91. PubMed ID: 17073995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature.
    Taban M; Dupps WJ; Mandell B; Perez VL
    Ocul Immunol Inflamm; 2006 Jun; 14(3):145-50. PubMed ID: 16766397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate.
    Sotiriadis D; Patsatsi A; Sotiriou E; Sotiriou E; Papagaryfallou I; Chrysomallis F
    J Dermatolog Treat; 2007; 18(5):315-8. PubMed ID: 17852633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
    Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.